vs

Side-by-side financial comparison of BYLINE BANCORP, INC. (BY) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $112.4M, roughly 1.8× BYLINE BANCORP, INC.). BYLINE BANCORP, INC. runs the higher net margin — 33.4% vs 6.7%, a 26.7% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 9.0%). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 6.4%).

Byline Bank is a bank headquartered in Chicago, Illinois, United States. It is the primary subsidiary of Byline Bancorp, Inc., a bank holding company, and the 4th largest SBA 7(a) lender.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

BY vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.8× larger
RGEN
$197.9M
$112.4M
BY
Growing faster (revenue YoY)
RGEN
RGEN
+4.6% gap
RGEN
13.6%
9.0%
BY
Higher net margin
BY
BY
26.7% more per $
BY
33.4%
6.7%
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
6.4%
BY

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BY
BY
RGEN
RGEN
Revenue
$112.4M
$197.9M
Net Profit
$37.6M
$13.3M
Gross Margin
52.5%
Operating Margin
9.0%
Net Margin
33.4%
6.7%
Revenue YoY
9.0%
13.6%
Net Profit YoY
33.0%
143.9%
EPS (diluted)
$0.83
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BY
BY
RGEN
RGEN
Q1 26
$112.4M
Q4 25
$117.0M
$197.9M
Q3 25
$115.7M
$188.8M
Q2 25
$110.5M
$182.4M
Q1 25
$103.1M
$169.2M
Q4 24
$104.7M
$174.1M
Q3 24
$101.8M
$154.9M
Q2 24
$99.4M
$154.1M
Net Profit
BY
BY
RGEN
RGEN
Q1 26
$37.6M
Q4 25
$34.5M
$13.3M
Q3 25
$37.2M
$14.9M
Q2 25
$30.1M
$14.9M
Q1 25
$28.2M
$5.8M
Q4 24
$30.3M
$-30.3M
Q3 24
$30.3M
$-654.0K
Q2 24
$29.7M
$3.3M
Gross Margin
BY
BY
RGEN
RGEN
Q1 26
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Operating Margin
BY
BY
RGEN
RGEN
Q1 26
Q4 25
40.1%
9.0%
Q3 25
43.1%
8.9%
Q2 25
35.2%
7.6%
Q1 25
36.4%
3.9%
Q4 24
38.6%
-17.7%
Q3 24
39.3%
-5.1%
Q2 24
40.4%
1.0%
Net Margin
BY
BY
RGEN
RGEN
Q1 26
33.4%
Q4 25
34.1%
6.7%
Q3 25
32.1%
7.9%
Q2 25
27.2%
8.2%
Q1 25
27.4%
3.4%
Q4 24
34.3%
-17.4%
Q3 24
29.8%
-0.4%
Q2 24
29.9%
2.2%
EPS (diluted)
BY
BY
RGEN
RGEN
Q1 26
$0.83
Q4 25
$0.77
$0.24
Q3 25
$0.82
$0.26
Q2 25
$0.66
$0.26
Q1 25
$0.64
$0.10
Q4 24
$0.68
$-0.55
Q3 24
$0.69
$-0.01
Q2 24
$0.68
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BY
BY
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$198.4M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$1.3B
$2.1B
Total Assets
$9.9B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BY
BY
RGEN
RGEN
Q1 26
$198.4M
Q4 25
$149.1M
$767.6M
Q3 25
$259.0M
$748.7M
Q2 25
$218.3M
$708.9M
Q1 25
$421.3M
$697.2M
Q4 24
$563.1M
$757.4M
Q3 24
$452.6M
$784.0M
Q2 24
$730.5M
$809.1M
Total Debt
BY
BY
RGEN
RGEN
Q1 26
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Stockholders' Equity
BY
BY
RGEN
RGEN
Q1 26
$1.3B
Q4 25
$1.3B
$2.1B
Q3 25
$1.2B
$2.1B
Q2 25
$1.2B
$2.1B
Q1 25
$1.1B
$2.0B
Q4 24
$1.1B
$2.0B
Q3 24
$1.1B
$2.0B
Q2 24
$1.0B
$2.0B
Total Assets
BY
BY
RGEN
RGEN
Q1 26
$9.9B
Q4 25
$9.7B
$2.9B
Q3 25
$9.8B
$2.9B
Q2 25
$9.7B
$2.9B
Q1 25
$9.6B
$2.9B
Q4 24
$9.5B
$2.8B
Q3 24
$9.4B
$2.8B
Q2 24
$9.6B
$2.9B
Debt / Equity
BY
BY
RGEN
RGEN
Q1 26
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BY
BY
RGEN
RGEN
Operating Cash FlowLast quarter
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BY
BY
RGEN
RGEN
Q1 26
Q4 25
$140.3M
$25.7M
Q3 25
$38.3M
$48.1M
Q2 25
$16.3M
$28.6M
Q1 25
$27.1M
$15.0M
Q4 24
$175.2M
$39.2M
Q3 24
$19.8M
$49.3M
Q2 24
$40.1M
$42.2M
Free Cash Flow
BY
BY
RGEN
RGEN
Q1 26
Q4 25
$136.3M
$17.6M
Q3 25
$38.0M
$43.4M
Q2 25
$15.2M
$21.5M
Q1 25
$25.0M
$11.4M
Q4 24
$171.2M
$33.6M
Q3 24
$19.1M
$42.3M
Q2 24
$39.4M
$37.4M
FCF Margin
BY
BY
RGEN
RGEN
Q1 26
Q4 25
116.5%
8.9%
Q3 25
32.8%
23.0%
Q2 25
13.7%
11.8%
Q1 25
24.3%
6.8%
Q4 24
163.5%
19.3%
Q3 24
18.8%
27.3%
Q2 24
39.7%
24.3%
Capex Intensity
BY
BY
RGEN
RGEN
Q1 26
Q4 25
3.4%
4.1%
Q3 25
0.3%
2.5%
Q2 25
1.0%
3.9%
Q1 25
2.0%
2.1%
Q4 24
3.8%
3.2%
Q3 24
0.6%
4.5%
Q2 24
0.7%
3.1%
Cash Conversion
BY
BY
RGEN
RGEN
Q1 26
Q4 25
4.06×
1.93×
Q3 25
1.03×
3.23×
Q2 25
0.54×
1.92×
Q1 25
0.96×
2.57×
Q4 24
5.78×
Q3 24
0.65×
Q2 24
1.35×
12.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons